Taught course

Cancer Pharmacology

London Metropolitan University · School of Human Sciences

Entry requirements

You will be required to have:

  • a lower second class (2.2) UK first degree (or equivalent) in an appropriate subject, for example pharmacology, biomedical science, biological science or medical genetics (these will be considered on an individual basis)

All applicants must be able to demonstrate proficiency in the English language.

Months of entry


Course content

Why study this course?

The use of chemotherapeutic agents to target and kill cancer cells is a central strategy in the treatment of cancers. This course describes the nature of the disease at the systems, cellular and molecular levels, and focuses on the drugs which are used to treat different cancers and on how they work.

More about this course

Worldwide the incidence of cancer is increasing, and is expected to reach 22 million new cases per year by 2030. In addition to treatments such as radiotherapy and surgery, chemotherapy has a vital role to play in prolonging the lives of patients.

The aims of this course are to:

  • provide you with an in-depth understanding of the molecular targets at which the different classes of anticancer drugs are aimed, and of how drug therapies are evolving;
  • review the biology of cancer with respect to genetics, pathological considerations, and the molecular changes within cells which are associated with the progression of the disease;
  • enhance intellectual and practical skills necessary for the collection, analysis, interpretation and understanding of scientific data;
  • deliver a programme of advanced study to equip you for a future career in anti-cancer drug development.


Assessment is a combination of coursework, which includes tests and essays, the research project and its oral defence and examination.

Modular structure

Core modules include:

· Cancer Pharmacology (core, 20 credits)

· Cancer: Diagnosis and Therapy (core, 20 credts)

· Medical Genetics and Genomics (core, 20 credits)

Option modules include:

· Advanced Drug Formulation Technologies (option, 20 credits)

· Bioinformatics and Molecular Modelling (option, 20 credits)

· Drug Discovery Technology (option, 20 credits)

Please refer to the course page on the London Met website for the full list of modules.

After the course

This course is primarily designed for those wishing to pursue a career in anti-cancer drug development, whether in academia or within the pharmaceutical industry. The programme provides an excellent basis for further research or stud

Qualification, course duration and attendance options

  • MSc
    full time
    12 months
    • Campus-based learningis available for this qualification
    part time
    24 months
    • Campus-based learningis available for this qualification

Course contact details

Course Enquiries
020 7133 4202